Literature DB >> 22679629

Effect of molecular size and modification pattern on the internalization of water soluble β-(1 → 3)-(1 → 4)-glucan by primary murine macrophages.

Mei Zhang1, Julian A Kim.   

Abstract

It has been shown that -(1→3)-(1→4)-glucans (BG34) from barley and oats can trigger recognition and internalization by murine and human macrophages. Increasing evidence has suggested that macrophage recognition and internalization of BG34 are dramatically affected by the purity of BG34, the molecular weight and chemical modification. In this study, we investigated the structural features of BG34 for macrophage recognition and internalization. We prepared homogeneous BG34s of 10 kDa (BG34-10),200 kDa (BG34-200) and 500 kDa (BG34-500) with high purity, and then introduced green fluorescence FITC to the reducing ends (Re) or main chain (Mc). The results of size exclusion chromatography, 13C NMR,fluorescence microscopy, FACS analyses and MTS assay demonstrated that non-toxic BG34 of 10 kDa(BG34-10) effectively trigger macrophage internalization. The internalization was adversely affected by modifying the main chain of BG34-10 but not the reducing end. Studies using blocking antibodies on several CD11b+ and CD11b− cells suggested that CD11b may play an important role in mediating macrophage internalization of BG34-10. Quantitative RT-PCR and intracellular cytokine stain revealed that macrophages generate increased level of CD11b and TNF-α in response to BG34-10. This study for the first time demonstrated the molecular size (10 kDa) and pattern of modification (reducing end modification)for BG34-10 to mediate macrophage internalization. Since BG34 is water soluble, biocompatible and biodegradable FDA-approved material, this mechanism of BG34-10 can be used to design drug delivery system targeting macrophages.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22679629     DOI: 10.1016/j.biocel.2012.02.018

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer.

Authors:  Mei Zhang; Liane Chun; Victor Sandoval; Hallie Graor; Jay Myers; Joseph Nthale; Peter Rauhe; Zachary Senders; Kevin Choong; Alex Y Huang; Julian Kim
Journal:  Oncoimmunology       Date:  2017-10-30       Impact factor: 8.110

2.  Metabolism and Biodegradation of β-Glucan in vivo.

Authors:  Ziming Zheng; Wenqi Tang; Weipeng Lu; Xu Mu; Yuxuan Liu; Xianglin Pan; Kaiping Wang; Yu Zhang
Journal:  Front Vet Sci       Date:  2022-06-03

3.  Non-viral nanoparticle delivers small interfering RNA to macrophages in vitro and in vivo.

Authors:  Mei Zhang; Yunxiang Gao; Kevin Caja; Bocheng Zhao; Julian A Kim
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 4.  Nanomedicine Strategies to Target Tumor-Associated Macrophages.

Authors:  Karin Binnemars-Postma; Gert Storm; Jai Prakash
Journal:  Int J Mol Sci       Date:  2017-05-04       Impact factor: 5.923

Review 5.  Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.

Authors:  Mei Zhang; Julian A Kim; Alex Yee-Chen Huang
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

Review 6.  β-Glucans: Relationships between Modification, Conformation and Functional Activities.

Authors:  Qiang Wang; Xiaojing Sheng; Aimin Shi; Hui Hu; Ying Yang; Li Liu; Ling Fei; Hongzhi Liu
Journal:  Molecules       Date:  2017-02-09       Impact factor: 4.411

7.  Immunomodulatory effect and safety of TNF-α RNAi mediated by oral yeast microcapsules in rheumatoid arthritis therapy.

Authors:  Nan Hu; Li Zhu; Li Zhang; Jing Wang; Yanhua Wang; Jing Luo; Lan He; Zhiming Hao; Long Zhang
Journal:  Mater Today Bio       Date:  2022-08-07

8.  The β-glucan from Lentinus edodes suppresses cell proliferation and promotes apoptosis in estrogen receptor positive breast cancers.

Authors:  Hui Xu; Siwei Zou; Xiaojuan Xu
Journal:  Oncotarget       Date:  2017-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.